Product

Human Rabies Immunoglobulin

Aliases

Human Rabies Immunoglobulin(HRIG)

1 clinical trial

1 indication

Indication

Rabies Post-exposure Prophylaxis

Clinical trial

A Phase III Clinical Trail to Evaluate the Efficacy,Safety,Pharmacokinetics and Immunogenicity Characteristics of GR1801 Injection for the Post-exposure Prophylaxis (PEP) of WHO Category 3 Rabies Exposure Patients.

Status: Recruiting, Estimated PCD: 2023-09-06